BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15251426)

  • 1. Recombinant HMGB1 with cytokine-stimulating activity.
    Li J; Wang H; Mason JM; Levine J; Yu M; Ulloa L; Czura CJ; Tracey KJ; Yang H
    J Immunol Methods; 2004 Jun; 289(1-2):211-23. PubMed ID: 15251426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGB1 as a cytokine and therapeutic target.
    Yang H; Wang H; Czura CJ; Tracey KJ
    J Endotoxin Res; 2002; 8(6):469-72. PubMed ID: 12697092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin).
    Rouhiainen A; Tumova S; Valmu L; Kalkkinen N; Rauvala H
    J Leukoc Biol; 2007 Jan; 81(1):49-58. PubMed ID: 16980512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1 as a DNA-binding cytokine.
    Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
    J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of the HMGB1 mutant as a competitive antagonist to HMGB1 induced cytokines release.
    Yuan Z; Chen J; Zhang Y; Peng Y
    Biochem Biophys Res Commun; 2008 Aug; 372(4):703-7. PubMed ID: 18515078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of human HMGB1 A box in E. coli and its inhibitory effects on monocytes].
    Zhu M; Cui B; Jiao YL; Wang LC; Qu YY; Sun XP; Liu XW; Xu J; Zhao YR
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):333-6. PubMed ID: 20368109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells.
    Thierry S; Gozlan J; Jaulmes A; Boniface R; Nasreddine N; Strauss F; Maréchal V
    AIDS; 2007 Jan; 21(3):283-92. PubMed ID: 17255735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
    Tang Y; Lv B; Wang H; Xiao X; Zuo X
    Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor angiogenesis by HMGB1 A box peptide.
    Zhang CL; Shu MG; Qi HW; Li LW
    Med Hypotheses; 2008; 70(2):343-5. PubMed ID: 17630223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
    Hreggvidsdottir HS; Ostberg T; Wähämaa H; Schierbeck H; Aveberger AC; Klevenvall L; Palmblad K; Ottosson L; Andersson U; Harris HE
    J Leukoc Biol; 2009 Sep; 86(3):655-62. PubMed ID: 19564572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of CpG DNA on HMGB1 release by murine macrophage cell lines.
    Jiang W; Li J; Gallowitsch-Puerta M; Tracey KJ; Pisetsky DS
    J Leukoc Biol; 2005 Oct; 78(4):930-6. PubMed ID: 16081598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytokine activity of HMGB1--extracellular escape of the nuclear protein.
    Sun NK; Chao CC
    Chang Gung Med J; 2005 Oct; 28(10):673-82. PubMed ID: 16382751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytokine activity of HMGB1.
    Yang H; Wang H; Czura CJ; Tracey KJ
    J Leukoc Biol; 2005 Jul; 78(1):1-8. PubMed ID: 15734795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mobility group box (HMGB) proteins of Plasmodium falciparum: DNA binding proteins with pro-inflammatory activity.
    Kumar K; Singal A; Rizvi MM; Chauhan VS
    Parasitol Int; 2008 Jun; 57(2):150-7. PubMed ID: 18234548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation.
    Lutz W; Stetkiewicz J
    Int J Occup Med Environ Health; 2004; 17(2):245-54. PubMed ID: 15387080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of recombinant human HMGB1 and anti-HMGB1 rabbit serum.
    Lin Q; Fang J; Fang D; Li B; Zhou H; Su SB
    Int Immunopharmacol; 2011 Jun; 11(6):646-51. PubMed ID: 21255697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1.
    Mullins GE; Sunden-Cullberg J; Johansson AS; Rouhiainen A; Erlandsson-Harris H; Yang H; Tracey KJ; Rauvala H; Palmblad J; Andersson J; Treutiger CJ
    Scand J Immunol; 2004 Dec; 60(6):566-73. PubMed ID: 15584967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAG and HMGB1 proteins: purification and biochemical analysis of recombination signal complexes.
    Bergeron S; Anderson DK; Swanson PC
    Methods Enzymol; 2006; 408():511-28. PubMed ID: 16793390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate.
    Zetterström CK; Jiang W; Wähämaa H; Ostberg T; Aveberger AC; Schierbeck H; Lotze MT; Andersson U; Pisetsky DS; Erlandsson Harris H
    J Leukoc Biol; 2008 Jan; 83(1):31-8. PubMed ID: 17913975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.